Zyflamend reduces LTB4 formation and prevents oral carcinogenesis in a 7,12-dimethylbenz[alpha]anthracene (DMBA)-induced hamster cheek pouch model.

Source:http://linkedlifedata.com/resource/pubmed/id/18687669

Download in:

View as

General Info

PMID
18687669